L-cysteine NAC
Selected indexed studies
- The Potential of N-Acetyl-L-Cysteine (NAC) in the Treatment of Psychiatric Disorders. (CNS Drugs, 2022) [PMID:35316513]
- N-Acetyl-L-Cysteine (NAC) Blunts Axitinib-Related Adverse Effects in Preclinical Models of Glioblastoma. (Cancer Med, 2024) [PMID:39377544]
- N-acetyl-l-cysteine averts ferroptosis by fostering glutathione peroxidase 4. (Cell Chem Biol, 2025) [PMID:40311609]
_Worker-drafted node — pending editorial review._
Connections
L-cysteine NAC helps
L-cysteine NAC protects against
Sources
- N-Acetylcysteine as an antioxidant and disulphide breaking agent: the reasons why. (2018) pubmed
- The Potential of N-Acetyl-L-Cysteine (NAC) in the Treatment of Psychiatric Disorders. (2022) pubmed
- N-Acetyl-L-Cysteine (NAC) Blunts Axitinib-Related Adverse Effects in Preclinical Models of Glioblastoma. (2024) pubmed
- N-acetyl-l-cysteine averts ferroptosis by fostering glutathione peroxidase 4. (2025) pubmed
- N-acetyl-L-cysteine (NAC) delays post-ovulatory oocyte aging in mouse. (2019) pubmed
- N-acetyl-l-cysteine. (1993) pubmed
- Pharmacokinetics of N-acetyl-l-cysteine in chickens. (2024) pubmed
- Treatment of military acoustic accidents with N-Acetyl-L-cysteine (NAC). (2019) pubmed
- N-acetylcysteine (NAC) differentially affects arterial medial calcification and bone formation: The role of l-cysteine and hydrogen sulphide. (2022) pubmed
- Inhibitory effects of zinc chloride (ZnCl(2)), n-acetyl-L-cysteine (NAC), and calcium/calmodulin dependent protein kinase II inhibitor (KN93) on Cd(2+)-induced abnormal cell morphology and membrane permeability. (2022) pubmed